{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:40:58Z","timestamp":1793724058666,"version":"4.6.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101497","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:05:23Z","timestamp":1748225123000},"page":"101497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["In-vivo-targeted gene delivery using adenovirus-antibody site-specific covalent conjugates"],"prefix":"10.1016","volume":"33","author":[{"given":"Paul J.","family":"Rice-Boucher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-8137","authenticated-orcid":false,"given":"Zhi Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101497_bib1","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41570-018-0039-1","article-title":"Synthetic materials at the forefront of gene delivery","volume":"2","author":"Lostal\u00e9-Seijo","year":"2018","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.omtm.2025.101497_bib3","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101497_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101497_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery Aspects of CRISPR\/Cas for in Vivo Genome Editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omtm.2025.101497_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41417-019-0157-z","article-title":"Autologous CAR T-cell therapies supply chain: challenges and opportunities?","volume":"27","author":"Papathanasiou","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib7","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1873-3468.13668","article-title":"Adenovirus vectors in hematopoietic stem cell genome editing","volume":"593","author":"Li","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2025.101497_bib8","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101497_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","article-title":"In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101497_bib10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ymthe.2020.05.005","article-title":"In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes","volume":"28","author":"Agarwal","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1671761","article-title":"In vivo generated human CAR T cells eradicate tumor cells","volume":"8","author":"Agarwal","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtm.2025.101497_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.omtm.2022.06.004","article-title":"In vivo generation of CAR T cells in the presence of human myeloid cells","volume":"26","author":"Ho","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101497_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006292","article-title":"Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering","volume":"11","author":"Michels","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omtm.2025.101497_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809158","article-title":"In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2025.101497_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101497_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/cancers10060201","article-title":"Designer Oncolytic Adenovirus: Coming of Age","volume":"10","author":"Baker","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.omtm.2025.101497_bib17","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ymthe.2022.01.034","article-title":"Adenovirus-based vaccines\u2014a platform for pandemic preparedness against emerging viral pathogens","volume":"30","author":"Coughlan","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib18","unstructured":"Two Billion Doses of AstraZeneca\u2019s COVID-19 Vaccine Supplied to Countries across the World Less than 12 Months after First Approval. (2021). AstraZeneca."},{"key":"10.1016\/j.omtm.2025.101497_bib19","article-title":"Adenovirus Strategies for Tissue-Specific Targeting","author":"Beatty","year":"2012","journal-title":"Applications of Viruses for Cancer Therapy"},{"key":"10.1016\/j.omtm.2025.101497_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/labinvest.2014.82","article-title":"Adenoviral targeting using genetically incorporated camelid single variable domains","volume":"94","author":"Kaliberov","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.omtm.2025.101497_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017925118","article-title":"The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody","volume":"118","author":"Smith","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib22","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1039\/D0SC01878C","article-title":"Power to the protein: enhancing and combining activities using the Spy toolbox","volume":"11","author":"Keeble","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.omtm.2025.101497_bib23","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib24","doi-asserted-by":"crossref","first-page":"26523","DOI":"10.1073\/pnas.1909653116","article-title":"Approaching infinite affinity through engineering of peptide\u2013protein interaction","volume":"116","author":"Keeble","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1073\/pnas.1519214113","article-title":"Programmable polyproteams built using twin peptide superglues","volume":"113","author":"Veggiani","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib26","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/jacs.7b13237","article-title":"SnoopLigase Catalyzes Peptide\u2013Peptide Locking and Enables Solid-Phase Conjugate Isolation","volume":"140","author":"Buldun","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtm.2025.101497_bib27","doi-asserted-by":"crossref","first-page":"E1176","DOI":"10.1073\/pnas.1315776111","article-title":"SpyLigase peptide\u2013peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture","volume":"111","author":"Fierer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib28","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1021\/acsnano.2c00909","article-title":"Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9\/gRNA Complex on Viral Capsid Surface","volume":"16","author":"Lu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtm.2025.101497_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.chembiol.2021.07.005","article-title":"DogCatcher allows loop-friendly protein-protein ligation","volume":"29","author":"Keeble","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.omtm.2025.101497_bib30","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.ymthe.2022.08.002","article-title":"Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2","volume":"30","author":"Dicks","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.virol.2006.01.032","article-title":"Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting","volume":"349","author":"Campos","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2025.101497_bib32","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.ymthe.2023.07.004","article-title":"Adenoviral vectors infect B lymphocytes in vivo","volume":"31","author":"Rice-Boucher","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib33","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101497_bib34","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/JVI.72.3.1844-1852.1998","article-title":"Characterization of an Adenovirus Vector Containing a Heterologous Peptide Epitope in the HI Loop of the Fiber Knob","volume":"72","author":"Krasnykh","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101497_bib69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101497_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.omtm.2025.101497_bib35","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/eji.201747168","article-title":"Standing out from the crowd: How to identify plasma cells","volume":"47","author":"Tellier","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2025.101497_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00215","article-title":"Human CD4+ T-Cells: A Role for Low-Affinity Fc Receptors","volume":"7","author":"Chauhan","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101497_bib37","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1073\/pnas.0711757105","article-title":"Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo","volume":"105","author":"Kalyuzhniy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101497_bib39","first-page":"2085","article-title":"In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model","volume":"141","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101497_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.omtm.2021.12.003","article-title":"Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5\/35++ vectors","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101497_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139538","article-title":"Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101497_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtm.2025.101497_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2015.1","article-title":"Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein","volume":"2","author":"van Erp","year":"2015","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omtm.2025.101497_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41417-017-0002-1","article-title":"Development of an adenovirus vector vaccine platform for targeting dendritic cells","volume":"25","author":"Sharma","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2021.04.009","article-title":"Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody","volume":"334","author":"Lee","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtm.2025.101497_bib46","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1128\/JVI.74.15.6875-6884.2000","article-title":"Ectodomain of Coxsackievirus and Adenovirus Receptor Genetically Fused to Epidermal Growth Factor Mediates Adenovirus Targeting to Epidermal Growth Factor Receptor-Positive Cells","volume":"74","author":"Dmitriev","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101497_bib47","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S1525-0016(16)43454-4","article-title":"Adenovirus Targeting to c-erbB-2 Oncoprotein by Single-Chain Antibody Using Recombinant Adapter Protein or Genetic Modification of Viral Capsid","volume":"5","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib48","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.1073\/pnas.1213653110","article-title":"Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters","volume":"110","author":"Dreier","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101497_bib49","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1128\/JVI.77.21.11367-11377.2003","article-title":"Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells","volume":"77","author":"Belousova","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101497_bib50","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/mthe.2001.0489","article-title":"Ablating Adenovirus Type 5 Fiber\u2013CAR Binding and HI Loop Insertion of the SIGYPLP Peptide Generate an Endothelial Cell-Selective Adenovirus","volume":"4","author":"Nicklin","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib51","doi-asserted-by":"crossref","DOI":"10.3791\/58480","article-title":"Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting","author":"J\u00f6nsson","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtm.2025.101497_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymthe.2005.03.006","article-title":"Combined Genetic and Chemical Capsid Modifications Enable Flexible and Efficient De- and Retargeting of Adenovirus Vectors","volume":"12","author":"Kreppel","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2016.06.022","article-title":"Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity","volume":"235","author":"Krutzke","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtm.2025.101497_bib54","author":"INVIVYD"},{"key":"10.1016\/j.omtm.2025.101497_bib56","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/d41586-022-04327-7","article-title":"Researchers welcome $3.5-million haemophilia gene therapy \u2014 but questions remain","volume":"612","author":"Naddaf","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101497_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1039324","article-title":"Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation","volume":"9","author":"Kadkhodazadeh","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtm.2025.101497_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01860-17","article-title":"Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types","volume":"8","author":"Kasaraneni","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.omtm.2025.101497_bib59","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.virol.2013.09.020","article-title":"Retargeting of gene expression using endothelium specific hexon modified adenoviral vector","volume":"447","author":"Kaliberov","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2025.101497_bib60","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101497_bib61","doi-asserted-by":"crossref","first-page":"eabc6659","DOI":"10.1126\/scitranslmed.abc6659","article-title":"Systemic cancer therapy with engineered adenovirus that evades innate immunity","volume":"12","author":"Atasheva","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101497_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114189","article-title":"In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector","volume":"158","author":"Lorincz","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtm.2025.101497_bib63","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijpara.2021.01.003","article-title":"Identification and characterization of a new 34 kDa MORN motif-containing sporozoite surface-exposed protein, Cp-P34, unique to Cryptosporidium","volume":"51","author":"Jaskiewicz","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.omtm.2025.101497_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43233-4","article-title":"High-volume hybridoma sequencing on the NeuroMabSeq platform enables efficient generation of recombinant monoclonal antibodies and scFvs for neuroscience research","volume":"13","author":"Mitchell","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101497_bib65","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1128\/jvi.70.10.7071-7078.1996","article-title":"Domains required for assembly of adenovirus type 2 fiber trimers","volume":"70","author":"Hong","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101497_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03187-1","article-title":"Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","author":"Luo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtm.2025.101497_bib67","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2017.11.012","article-title":"Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells","volume":"26","author":"Hung","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101497_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33787-8","article-title":"Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:54:36Z","timestamp":1759863276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000920"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101497","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vivo-targeted gene delivery using adenovirus-antibody site-specific covalent conjugates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101497"}}